Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy

par Ramsha Aamir, Cameron Fyffe, Netanel Korin, Daniel A. Lawrence, Enming J. Su, Mathumai Kanapathipillai
Publié 2021

Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape

par Zachary M. Huttinger, Laura M. Haynes, Andrew Yee, Colin A. Kretz, Matthew L. Holding, David R. Siemieniak, Daniel A. Lawrence, David Ginsburg
Publié 2021

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

par Yu Zuo, Mark Warnock, Alyssa Harbaugh, Srilakshmi Yalavarthi, Kelsey Gockman, Melanie Zuo, Jacqueline A. Madison, Jason S. Knight, Yogendra Kanthi, Daniel A. Lawrence
Publié 2021

CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by <named-content content-type="genus-species">Acinetobacter baumannii</named-content> That Inactivates Coagulation Fact...

par Ursula Waack, Mark Warnock, Andrew Yee, Zachary Huttinger, Sara Smith, Ayush Kumar, Alban Deroux, David Ginsburg, Harry L. T. Mobley, Daniel A. Lawrence, Maria Sandkvist
Publié 2018